Identification and Validation of Lipid Metabolism-Related Biomarkers GPD1 and CEBPD in Metabolic Dysfunction-Associated Steatohepatitis
This study highlights the importance of GPD1 and CEBPD as potential diagnostic biomarkers and therapeutic targets for MASH, providing a theoretical and experimental foundation for improving early diagnostic strategies and developing interventions targeting inflammation and lipid metabolism dysregulation in metabolic liver disease.
Authors
- Jianyu Zhou (ORCID: https://orcid.org/0000-0002-1227-2316)
- Fenfang Chen (ORCID: https://orcid.org/0000-0003-3758-0304)
- Bin Huang (ORCID: https://orcid.org/0000-0003-2325-1059)
- Chunying Xiao (ORCID: https://orcid.org/0000-0002-3847-715X)
Institutions
- Wenzhou Medical University (CN)
- Taizhou Central Hospital (CN)
- Zhejiang Taizhou Hospital (CN)
- Taizhou University (CN)
Publication Details
- Journal
- Journal of Inflammation Research
- Published
- 2025-10-01
- DOI
- https://doi.org/10.2147/jir.s524204
- Citations
- 1
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.35